Regeneron Pharmaceuticals, Inc. (BVMF:REGN34)

Regeneron Pharmaceuticals Statistics

Total Valuation

BVMF:REGN34 has a market cap or net worth of BRL 393.75 billion. The enterprise value is 308.78 billion.

Market Cap	393.75B
Enterprise Value	308.78B

Important Dates

The next estimated earnings date is Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 18, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-4.39%
Shares Change (QoQ)	-1.29%
Owned by Insiders (%)	3.76%
Owned by Institutions (%)	87.79%
Float	98.56M

Valuation Ratios

The trailing PE ratio is 16.14 and the forward PE ratio is 15.77.

PE Ratio	16.14
Forward PE	15.77
PS Ratio	5.19
PB Ratio	2.39
P/TBV Ratio	2.50
P/FCF Ratio	17.50
P/OCF Ratio	14.57
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.28, with an EV/FCF ratio of 13.72.

EV / Earnings	12.66
EV / Sales	4.09
EV / EBITDA	13.28
EV / EBIT	15.23
EV / FCF	13.72

Financial Position

The company has a current ratio of 4.06, with a Debt / Equity ratio of 0.09.

Current Ratio	4.06
Quick Ratio	3.19
Debt / Equity	0.09
Debt / EBITDA	0.62
Debt / FCF	0.64
Interest Coverage	90.81

Financial Efficiency

Return on equity (ROE) is 15.19% and return on invested capital (ROIC) is 7.27%.

Return on Equity (ROE)	15.19%
Return on Assets (ROA)	6.16%
Return on Invested Capital (ROIC)	7.27%
Return on Capital Employed (ROCE)	10.70%
Revenue Per Employee	4.99M
Profits Per Employee	1.60M
Employee Count	15,106
Asset Turnover	0.37
Inventory Turnover	2.46

Taxes

In the past 12 months, BVMF:REGN34 has paid 3.02 billion in taxes.

Income Tax	3.02B
Effective Tax Rate	11.02%

Stock Price Statistics

The stock price has decreased by -13.64% in the last 52 weeks. The beta is 0.39, so BVMF:REGN34's price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	-13.64%
50-Day Moving Average	57.55
200-Day Moving Average	56.04
Relative Strength Index (RSI)	54.13
Average Volume (20 Days)	1,533

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.58

Income Statement

In the last 12 months, BVMF:REGN34 had revenue of BRL 75.93 billion and earned 24.40 billion in profits. Earnings per share was 221.67.

Revenue	75.93B
Gross Profit	34.80B
Operating Income	20.37B
Pretax Income	27.42B
Net Income	24.40B
EBITDA	23.17B
EBIT	20.37B
Earnings Per Share (EPS)	221.67

Balance Sheet

The company has 45.00 billion in cash and 14.42 billion in debt, giving a net cash position of 85.40 billion.

Cash & Cash Equivalents	45.00B
Total Debt	14.42B
Net Cash	85.40B
Net Cash Per Share	n/a
Equity (Book Value)	164.99B
Book Value Per Share	1,604.93
Working Capital	72.24B

Cash Flow

In the last 12 months, operating cash flow was 27.03 billion and capital expenditures -4.53 billion, giving a free cash flow of 22.50 billion.

Operating Cash Flow	27.03B
Capital Expenditures	-4.53B
Free Cash Flow	22.50B
FCF Per Share	n/a

Margins

Gross margin is 45.83%, with operating and profit margins of 26.83% and 32.13%.

Gross Margin	45.83%
Operating Margin	26.83%
Pretax Margin	36.11%
Profit Margin	32.13%
EBITDA Margin	30.52%
EBIT Margin	26.83%
FCF Margin	29.63%

Dividends & Yields

This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 0.33%.

Dividend Per Share	0.22
Dividend Yield	0.33%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	0.10%
Buyback Yield	4.39%
Shareholder Yield	4.72%
Earnings Yield	6.20%
FCF Yield	5.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on November 28, 2022. It was a forward split with a ratio of 12.

Last Split Date	Nov 28, 2022
Split Type	Forward
Split Ratio	12

Scores

BVMF:REGN34 has an Altman Z-Score of 6.89 and a Piotroski F-Score of 4.

Altman Z-Score	6.89
Piotroski F-Score	4